Aatmaj Healthcare Ltd vs Clinitech Laboratory Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aatmaj Healthcare Ltd is ₹ 22.8 as of 23 Oct 15:30 . The P/E Ratio of Aatmaj Healthcare Ltd is 0 as of March 2025 .The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 . The Market Cap of Aatmaj Healthcare Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 . The Dividend Payout of Aatmaj Healthcare Ltd changed from 12.84 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aatmaj Healthcare Ltd

Aatmaj Healthcare Limited was originally incorporated under the name Aatmaj Healthcare Private Limited' on March 10, 2014 issued by the RoC, Gujarat.
Thereafter, the Company was converted to Public Limited Company and name of the Company was changed to Aatmaj Healthcare Limited' vide fresh Certificate of Incorporation dated December 06, 2022.
The Company is a rapidly growing organization to establish itself as a leading healthcare provider, utilizing modern medicinal practices and advanced infrastructure for medical and surgical care solutions. The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services.
The main activities of the Company include operation of multidisciplinary private hospitals and clinics.
The healthcare facilities consist of advanced technology and doctors, nurses and other healthcare professionals follow treatment protocols that match acceptable standards.

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

FAQs for the comparison of Aatmaj Healthcare Ltd and Clinitech Laboratory Ltd

Which company has a larger market capitalization, Aatmaj Healthcare Ltd or Clinitech Laboratory Ltd?

Market cap of Aatmaj Healthcare Ltd is 51 Cr while Market cap of Clinitech Laboratory Ltd is 7 Cr

What are the key factors driving the stock performance of Aatmaj Healthcare Ltd and Clinitech Laboratory Ltd?

The stock performance of Aatmaj Healthcare Ltd and Clinitech Laboratory Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aatmaj Healthcare Ltd and Clinitech Laboratory Ltd?

As of October 25, 2026, the Aatmaj Healthcare Ltd stock price is INR ₹22.8. On the other hand, Clinitech Laboratory Ltd stock price is INR ₹32.0.

How do dividend payouts of Aatmaj Healthcare Ltd and Clinitech Laboratory Ltd compare?

To compare the dividend payouts of Aatmaj Healthcare Ltd and Clinitech Laboratory Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.